Literature DB >> 19073739

Limited effects of fasting on hepatitis B virus (HBV) biosynthesis in HBV transgenic mice.

Lie Li1, Claudia E Oropeza, Klaus H Kaestner, Alan McLachlan.   

Abstract

Nuclear receptors have a unique role in governing hepatitis B virus (HBV) transcription and replication. Hepatocyte nuclear factor 4alpha (HNF4alpha) and retinoid X receptor alpha (RXRalpha) plus peroxisome proliferator-activated receptor alpha (PPARalpha) have been shown to support viral biosynthesis in nonhepatoma cells in the absence of additional liver-enriched transcription factors. However, the in vivo importance of these nuclear receptors in HBV biosynthesis has been investigated only to a limited extent. Fasting has been shown to activate gluconeogenesis, in part, by activating PPARgamma coactivator 1 alpha, which in turn leads to activation of HNF4alpha- and RXRalpha/PPARalpha-mediated transcription. As HBV pregenomic RNA synthesis is primarily believed to be regulated by HNF4alpha under normal physiological conditions, it was of interest to determine the effect of fasting on the levels of HBV RNA and DNA synthesis. Fasting was shown to rather modestly increase the levels of viral proteins, transcripts, and replication intermediates in the HBV transgenic mouse model of chronic viral infection, suggesting that caloric restriction may modulate viremia to some extent during natural infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19073739      PMCID: PMC2643774          DOI: 10.1128/JVI.02208-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

Review 1.  Metabolic control through the PGC-1 family of transcription coactivators.

Authors:  Jiandie Lin; Christoph Handschin; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

Review 2.  Transcriptional control of hepadnavirus gene expression.

Authors:  H Schaller; M Fischer
Journal:  Curr Top Microbiol Immunol       Date:  1991       Impact factor: 4.291

3.  PGC-1alpha controls hepatitis B virus through nutritional signals.

Authors:  Amir Shlomai; Nir Paran; Yosef Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-16       Impact factor: 11.205

4.  Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.

Authors:  J C Yoon; P Puigserver; G Chen; J Donovan; Z Wu; J Rhee; G Adelmant; J Stafford; C R Kahn; D K Granner; C B Newgard; B M Spiegelman
Journal:  Nature       Date:  2001-09-13       Impact factor: 49.962

5.  In vivo regulation of hepatitis B virus replication by peroxisome proliferators.

Authors:  L G Guidotti; C M Eggers; A K Raney; S Y Chi; J M Peters; F J Gonzalez; A McLachlan
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes.

Authors:  R B Vega; J M Huss; D P Kelly
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

7.  Mechanisms of inhibition of nuclear hormone receptor-dependent hepatitis B virus replication by hepatocyte nuclear factor 3beta.

Authors:  Hong Tang; Alan McLachlan
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Hepatitis B virus transcription and replication.

Authors:  H Tang; K E Banks; A L Anderson; A McLachlan
Journal:  Drug News Perspect       Date:  2001-08

9.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.

Authors:  S S Lee; T Pineau; J Drago; E J Lee; J W Owens; D L Kroetz; P M Fernandez-Salguero; H Westphal; F J Gonzalez
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

10.  Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis.

Authors:  James Rhee; Yusuke Inoue; J Cliff Yoon; Pere Puigserver; Melina Fan; Frank J Gonzalez; Bruce M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-21       Impact factor: 11.205

View more
  9 in total

1.  Hepatitis B virus molecular biology and pathogenesis.

Authors:  R Jason Lamontagne; Sumedha Bagga; Michael J Bouchard
Journal:  Hepatoma Res       Date:  2016-07-01

2.  Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.

Authors:  Luhua Qiao; Jianhua Sui; Guangxiang Luo
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

3.  Limited effects of bile acids and small heterodimer partner on hepatitis B virus biosynthesis in vivo.

Authors:  Vanessa C Reese; David D Moore; Alan McLachlan
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

4.  GCN5 acetyltransferase inhibits PGC1α-induced hepatitis B virus biosynthesis.

Authors:  Xiaohui Tian; Fei Zhao; Zhikui Cheng; Ming Zhou; Xiaoguang Zhi; Jiafu Li; Kanghong Hu
Journal:  Virol Sin       Date:  2013-07-02       Impact factor: 4.327

5.  Peroxisome proliferator-activated receptor gamma Coactivator 1alpha and small heterodimer partner differentially regulate nuclear receptor-dependent hepatitis B virus biosynthesis.

Authors:  Caitlin R Ondracek; Christel N Rushing; Vanessa C Reese; Claudia E Oropeza; Alan McLachlan
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

6.  Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection.

Authors:  Christine I Wooddell; David B Rozema; Markus Hossbach; Matthias John; Holly L Hamilton; Qili Chu; Julia O Hegge; Jason J Klein; Darren H Wakefield; Claudia E Oropeza; Jochen Deckert; Ingo Roehl; Kerstin Jahn-Hofmann; Philipp Hadwiger; Hans-Peter Vornlocher; Alan McLachlan; David L Lewis
Journal:  Mol Ther       Date:  2013-02-26       Impact factor: 11.454

7.  Hepatic deficiency of the pioneer transcription factor FoxA restricts hepatitis B virus biosynthesis by the developmental regulation of viral DNA methylation.

Authors:  Vanessa C McFadden; Rasha E Shalaby; Saira Iram; Claudia E Oropeza; Jennifer A Landolfi; Alexander V Lyubimov; Mark Maienschein-Cline; Stefan J Green; Klaus H Kaestner; Alan McLachlan
Journal:  PLoS Pathog       Date:  2017-02-24       Impact factor: 6.823

8.  Farnesoid X receptor agonist for the treatment of chronic hepatitis B: A safety study.

Authors:  Robin Erken; Patrice Andre; Elise Roy; Neeltje Kootstra; Noelie Barzic; Hugo Girma; Christian Laveille; Pauline Radreau-Pierini; Raphael Darteil; Jacky Vonderscher; Pietro Scalfaro; Pisit Tangkijvanich; Robert Flisiak; Henk Reesink
Journal:  J Viral Hepat       Date:  2021-09-29       Impact factor: 3.517

Review 9.  Autophagy in viral replication and pathogenesis.

Authors:  Donna Sir; Jing-hsiung James Ou
Journal:  Mol Cells       Date:  2010-01-08       Impact factor: 5.034

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.